The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy.
Saved in:
| Title: | The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy. |
|---|---|
| Authors: | Bajaj JS; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Fagan A; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Gavis EA; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Mousel T; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Gallagher ML; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Puri P; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Fuchs M; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Davis BC; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Hylemon PB; Department of Microbiology and Immunology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Zhou H; Department of Microbiology and Immunology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA., Ahluwalia V; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.; Center for Advanced Brain Imaging, Georgia Institute of Technology, Atlanta, Georgia, USA., Cadrain R; Collaborative Advanced Research Imaging Center, Virginia Commonwealth University, Richmond, Virginia, USA., Sikaroodi M; Microbiome Analysis Center, George Mason University, Manassas, Virginia, USA., Gillevet PM; Microbiome Analysis Center, George Mason University, Manassas, Virginia, USA. |
| Source: | Hepatology communications [Hepatol Commun] 2024 Feb 03; Vol. 8 (2). Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024). |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38315140 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bajaj+JS%22">Bajaj JS</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Fagan+A%22">Fagan A</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Gavis+EA%22">Gavis EA</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Mousel+T%22">Mousel T</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Gallagher+ML%22">Gallagher ML</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Puri+P%22">Puri P</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Fuchs+M%22">Fuchs M</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Davis+BC%22">Davis BC</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Hylemon+PB%22">Hylemon PB</searchLink>; Department of Microbiology and Immunology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+H%22">Zhou H</searchLink>; Department of Microbiology and Immunology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Ahluwalia+V%22">Ahluwalia V</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.; Center for Advanced Brain Imaging, Georgia Institute of Technology, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Cadrain+R%22">Cadrain R</searchLink>; Collaborative Advanced Research Imaging Center, Virginia Commonwealth University, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Sikaroodi+M%22">Sikaroodi M</searchLink>; Microbiome Analysis Center, George Mason University, Manassas, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Gillevet+PM%22">Gillevet PM</searchLink>; Microbiome Analysis Center, George Mason University, Manassas, Virginia, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101695860%22">Hepatology communications</searchLink> [Hepatol Commun] 2024 Feb 03; Vol. 8 (2). <i>Date of Electronic Publication: </i>2024 Feb 03 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101695860 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2471-254X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222471254X%22">2471254X </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38315140 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HC9.0000000000000384 Languages: – Code: eng Text: English Titles: – TitleFull: The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bajaj JS – PersonEntity: Name: NameFull: Fagan A – PersonEntity: Name: NameFull: Gavis EA – PersonEntity: Name: NameFull: Mousel T – PersonEntity: Name: NameFull: Gallagher ML – PersonEntity: Name: NameFull: Puri P – PersonEntity: Name: NameFull: Fuchs M – PersonEntity: Name: NameFull: Davis BC – PersonEntity: Name: NameFull: Hylemon PB – PersonEntity: Name: NameFull: Zhou H – PersonEntity: Name: NameFull: Ahluwalia V – PersonEntity: Name: NameFull: Cadrain R – PersonEntity: Name: NameFull: Sikaroodi M – PersonEntity: Name: NameFull: Gillevet PM IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 02 Text: 2024 Feb 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2471-254X Numbering: – Type: volume Value: 8 – Type: issue Value: 2 Titles: – TitleFull: Hepatology communications Type: main |
| ResultId | 1 |